QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
OTCMKTS:RHHBY

Roche - RHHBY Stock Forecast, Price & News

$42.28
+0.28 (+0.67%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$41.95
$42.31
50-Day Range
$38.21
$42.93
52-Week Range
$37.88
$53.86
Volume
1.13 million shs
Average Volume
1.77 million shs
Market Capitalization
$288.77 billion
P/E Ratio
N/A
Dividend Yield
1.86%
Price Target
$263.00

Roche MarketRank™ Forecast

Analyst Rating
Hold
2.36 Rating Score
Upside/​Downside
522.0% Upside
$263.00 Price Target
Short Interest
Healthy
0.03% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.77mentions of Roche in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
0.37%
From $2.68 to $2.69 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.69 out of 5 stars

RHHBY stock logo

About Roche (OTCMKTS:RHHBY) Stock

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Receive RHHBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.

RHHBY Stock News Headlines

Roche (RHHBY) Influenza Drug Gets FDA Nod for Children
Analysts Set Roche Holding AG (OTCMKTS:RHHBY) PT at $263.00
Roche (OTCMKTS:RHHBY) Price Target Cut to CHF 325
Roche 1H Sales CHF32.29B - MarketWatch
See More Headlines
Receive RHHBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.

RHHBY Company Calendar

Today
8/15/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:RHHBY
CIK
N/A
Employees
100,920
Year Founded
1896

Price Target and Rating

Average Stock Price Forecast
$263.00
High Stock Price Forecast
$400.00
Low Stock Price Forecast
$48.00
Forecasted Upside/Downside
+522.0%
Consensus Rating
Hold
Rating Score (0-4)
2.36
Research Coverage
11 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$68.72 billion
Cash Flow
$3.47 per share
Book Value
$4.54 per share

Miscellaneous

Outstanding Shares
6,830,000,000
Free Float
N/A
Market Cap
$288.77 billion
Optionable
Not Optionable
Beta
0.43

Social Links


Key Executives

  • Dr. Severin Schwan Ph.D. (Age 55)
    CEO & Exec. Director
    Comp: $7.69M
  • Dr. Alan Hippe (Age 55)
    Chief Financial & Information Officer
    Comp: $4.41M
  • Ms. Cristina A. Wilbur (Age 55)
    Chief People Officer
    Comp: $3.16M
  • Dr. Johannes Carolus Clevers M.D. (Age 65)
    Ph.D., Head of Roche Pharma Research & Early Devel.
    Comp: $358.07k
  • Dr. Thomas Schinecker (Age 47)
    Chief Exec. Officer of Roche Diagnostics
    Comp: $3.02M
  • Mr. William N. Anderson (Age 56)
    Chief Exec. Officer of Roche Pharmaceuticals
    Comp: $6.64M
  • Dr. Karl Mahler
    Head of Investor Relations
  • Ms. Claudia Bockstiegel (Age 58)
    Gen. Counsel
  • Ms. Pascale Schmidt (Age 49)
    Chief Compliance Officer
  • Ms. Barbara Schadler (Age 60)
    Head of Group Communications













RHHBY Stock - Frequently Asked Questions

Should I buy or sell Roche stock right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Roche in the last year. There are currently 1 sell rating, 5 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" RHHBY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RHHBY, but not buy additional shares or sell existing shares.
View RHHBY analyst ratings
or view top-rated stocks.

What is Roche's stock price forecast for 2022?

11 brokerages have issued 1-year target prices for Roche's stock. Their RHHBY share price forecasts range from $48.00 to $400.00. On average, they predict the company's share price to reach $263.00 in the next year. This suggests a possible upside of 522.0% from the stock's current price.
View analysts price targets for RHHBY
or view top-rated stocks among Wall Street analysts.

How have RHHBY shares performed in 2022?

Roche's stock was trading at $51.69 at the beginning of 2022. Since then, RHHBY shares have decreased by 18.2% and is now trading at $42.28.
View the best growth stocks for 2022 here
.

Are investors shorting Roche?

Roche saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 2,230,400 shares, a decline of 21.1% from the July 15th total of 2,827,400 shares. Based on an average trading volume of 2,691,500 shares, the days-to-cover ratio is presently 0.8 days.
View Roche's Short Interest
.

How often does Roche pay dividends? What is the dividend yield for Roche?

Roche declared a dividend on Tuesday, March 15th. Stockholders of record on Friday, March 18th will be given a dividend of $0.7922 per share on Monday, March 28th. This represents a dividend yield of 1.68%. The ex-dividend date is Thursday, March 17th.
Read our dividend analysis for RHHBY
.

Is Roche a good dividend stock?

Roche (OTCMKTS:RHHBY) pays an annual dividend of $0.78 per share and currently has a dividend yield of 1.86%.
Read our dividend analysis for RHHBY.

What is Roche's stock symbol?

Roche trades on the OTCMKTS under the ticker symbol "RHHBY."

Who are Roche's major shareholders?

Roche's stock is owned by a number of retail and institutional investors. Top institutional investors include Saratoga Research & Investment Management (0.02%), Cullen Capital Management LLC (0.02%), Boston Common Asset Management LLC (0.01%), Todd Asset Management LLC (0.01%), Cardinal Capital Management Inc. (0.01%) and Osher Van de Voorde Investment Management (0.01%).

How do I buy shares of Roche?

Shares of RHHBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Roche's stock price today?

One share of RHHBY stock can currently be purchased for approximately $42.28.

How much money does Roche make?

Roche (OTCMKTS:RHHBY) has a market capitalization of $288.77 billion and generates $68.72 billion in revenue each year.

How many employees does Roche have?

The company employs 100,920 workers across the globe.

Does Roche have any subsidiaries?
The following companies are subsidiares of Roche: 454 Life Sciences, Adheron Therapeutics, Adheron Therapeutics Inc., Anadys Pharmaceuticals, Anadys Pharmaceuticals Inc., Ariosa Diagnostics, Ariosa Diagnostics Inc., Arius Research, Ascur Versicherungsvermittlungs GmbH, BINA Technology, Bina Technologies Inc., BioImagene, BioVeris, BioVeris Corporation, Biopharm AG, Boehringer Mannheim, Borean Pharma, Chemical Manufacturing and Trading Company Limited, Chugai Pharmaceutical Co. Ltd., Disetronic Holding AG, Dutalys GmbH, F. Hoffmann-La Roche Ltd, F. Hoffmann-La Roche Ltd / Jordan P.S.C., FLLC "Roche Products Limited", FMI Germany GmbH, Flatiron Health, Flatiron Health Inc., ForSight Labs, ForSight VISION4 Inc., Foundation Medicine, Foundation Medicine Inc., Foundation Medicine Securities Corporation, Galenus Mannheim Pharma GmbH, GeneWEAVE, GeneWEAVE Biosciences Inc., Genentech, Genentech Inc., Genentech P.R. Inc., Genentech USA Inc., Genia Technologies, Hoffmann - La Roche Ltd, Hoffmann-La Roche Inc., Hoffmann-La Roche Limited, Hoffmann-La Roche Products Limited, I5 Surviving Corp., IGEN International Inc., IGEN LS LLC, IQuum, IQuum Inc., Ignyta, Ignyta Inc., Inflazome, Infogenetik Moleküler Bilgi Hizmetleri Anonim Sirketi, Institut Roche SAS, InterMune, InterMune Holdings Limited, InterMune Inc., InterMune International AG, Jecure Therapeutics Inc., Kapa Biosystems, Kapa Biosystems (Pty) Ltd, Kapa Biosystems Inc., Limited Liability Company Roche Diabetes Care Rus, Limited Liability Company Roche Diagnostics Rus, MTM Laboratories, Marcadia Biotech, Medingo Ltd., Medingo Medical Solutions, Memory Pharmaceuticals, Memory Pharmaceuticals Corp., Mirus, Museum Tinguely AG, N.V. Roche S.A., P.T. Roche Indonesia, PVT Probenverteiltechnik GmbH, Phaor AG, Piramed, Productos Roche (El Salvador) S.A. de C.V., Productos Roche (Honduras) S.A., Productos Roche (Nicaragua) S.A., Productos Roche (Panama) S.A., Productos Roche Dominicana S.R.L., Productos Roche Guatemala (Sociedad Anónima), Productos Roche Interamericana S.A. (PRISA), Productos Roche Química Farmacéutica S.A., Productos Roche S.A., Productos Roche S.A. Química e Industrial, Productos Roche S.A. de C.V., Produtos Roche Químicos e Farmacêuticos S.A., Promedior, Rabbit-Air Ltd, RoDiagnostics Egypt for Trading S.A.E, Roche (China) Holding Ltd., Roche (Hellas) S.A., Roche (Hungary) Ltd, Roche (Malaysia) Sdn. Bhd., Roche (Philippines) Inc., Roche (Shanghai) Pharmaceuticals Consulting Co. Ltd, Roche (Shanghai) Pharmaceuticals Trading Co. Ltd., Roche - Moscow Ltd., Roche AB, Roche Algérie SPA, Roche Austria GmbH, Roche Bangladesh Limited, Roche Beteiligungs GmbH, Roche Biomedical Laboratories Inc., Roche Bolivia SRL., Roche Bulgaria EOOD, Roche Cameroun SARL, Roche Capital Market Ltd, Roche Capital Services Ltd., Roche Catalyst Investments Ltd., Roche Chemische Unternehmungen AG, Roche Chile Limitada, Roche Côte d’Ivoire SARL, Roche DC Japan K. K., Roche DC México S.A. de C.V., Roche Deutschland Holding GmbH, Roche Diabetes Care (Switzerland) Ltd, Roche Diabetes Care Argentina S.A., Roche Diabetes Care Asia Pacific Pte. Ltd., Roche Diabetes Care Australia Pty Limited, Roche Diabetes Care Austria GmbH, Roche Diabetes Care Brasil Ltda., Roche Diabetes Care Deutschland GmbH, Roche Diabetes Care France SAS, Roche Diabetes Care GmbH, Roche Diabetes Care Inc., Roche Diabetes Care India Private Limited, Roche Diabetes Care Italy S.p.A., Roche Diabetes Care Limited, Roche Diabetes Care Middle East FZCO, Roche Diabetes Care Nederland B.V., Roche Diabetes Care Polska sp. z o.o., Roche Diabetes Care South Africa Proprietary Limited, Roche Diabetes Care Spain S.L., Roche Diagnostica Brasil Ltda., Roche Diagnostics (Hellas) S.A., Roche Diagnostics (Hong Kong) Limited, Roche Diagnostics (Malaysia) Sdn. Bhd., Roche Diagnostics (Shanghai) Ltd., Roche Diagnostics (Suzhou) Limited, Roche Diagnostics (Switzerland) Ltd, Roche Diagnostics (Thailand) Limited, Roche Diagnostics Asia Pacific Pte. Ltd., Roche Diagnostics Australia Pty. Limited, Roche Diagnostics Belgium NV, Roche Diagnostics Corporation, Roche Diagnostics Deutschland GmbH, Roche Diagnostics France SAS, Roche Diagnostics GmbH, Roche Diagnostics Hematology Inc., Roche Diagnostics India Private Limited, Roche Diagnostics International Ltd, Roche Diagnostics K.K., Roche Diagnostics Korea Co. Ltd., Roche Diagnostics Limited, Roche Diagnostics Ltd., Roche Diagnostics Middle East FZCO, Roche Diagnostics NZ Limited, Roche Diagnostics Nederland B.V., Roche Diagnostics Norge A/S, Roche Diagnostics Operations Inc., Roche Diagnostics Oy, Roche Diagnostics Polska Sp. z o.o., Roche Diagnostics Proprietary Limited, Roche Diagnostics S.L., Roche Diagnostics S.p.A., Roche Diagnostics Scandinavia AB, Roche Diagnostics Turkey Anonim Sirketi, Roche Diagnostics a/s, Roche Ecuador S.A., Roche Eesti OÜ, Roche Egypt LLC, Roche Egypt for Manufacturing and Trading SAE, Roche Farma (Peru) S.A., Roche Farma S.A., Roche Farmacêutica Química Lda., Roche Finance Europe B.V., Roche Finance Ltd, Roche Financial Investments Ltd., Roche Financial Management Ltd., Roche Financial Services Ltd., Roche Forum Buonas Ltd, Roche Georgia LLC, Roche Glycart, Roche Glycart Ltd, Roche Health Solutions Inc., Roche Holding (UK) Limited, Roche Holdings Inc., Roche Hong Kong Limited, Roche Innovation Center Copenhagen A/S, Roche Innovatis, Roche International Ltd., Roche International Ltd. (Montevideo Branch), Roche Intertrade Limited, Roche Ireland Limited, Roche Kazakhstan LLP, Roche Kenya Limited, Roche Korea Company Ltd., Roche Laboratories Inc., Roche Latvija SIA, Roche Lebanon S.A.R.L., Roche Long Term Foundation, Roche Makedonija DOOEL, Roche Molecular Systems Inc., Roche Myanmar Company Limited, Roche Müstahzarlari Sanayi Anonim Sirketi, Roche Nederland B.V., Roche NimbleGen, Roche Norge A/S, Roche Operations Ltd., Roche Oy, Roche PVT GmbH, Roche Pakistan Limited, Roche Palo Alto LLC, Roche Pars Co. (Ltd.), Roche Pharma (Switzerland) Ltd, Roche Pharma AG, Roche Pharmaceuticals (Israel) Ltd., Roche Pharmaceuticals Middle East FZCO, Roche Pharmholding B.V., Roche Polska Sp. z o.o., Roche Privacy GmbH, Roche Products (India) Private Limited, Roche Products (Ireland) Limited, Roche Products (Mauritius) Ltd, Roche Products (New Zealand) Limited, Roche Products (Proprietary) Limited, Roche Products Ghana Limited, Roche Products Inc., Roche Products Limited, Roche Products Ltd., Roche Products Pty. Limited, Roche Products Saudi Arabia LLC, Roche R&D Center (China) Ltd., Roche Real Estate Services Mannheim GmbH, Roche Registration GmbH, Roche Registration Limited, Roche Romania S.R.L., Roche S.A., Roche S.p.A., Roche SAS, Roche Sequencing Solutions Inc., Roche Services (Asia Pacific) Sdn. Bhd., Roche Services (Europe) Ltd, Roche Services Americas Sociedad de Responsabilidad Limitada, Roche Services Holdings Ltd., Roche Servicios S.A., Roche Servicios de México S.A. de C.V., Roche Singapore Pte. Ltd., Roche Singapore Technical Operations Pte. Ltd., Roche Sistemas de Diagnósticos Sociedade Unipessoal Lda., Roche Slovensko S.R.O., Roche TCRC Inc., Roche Thailand Limited, Roche Tunisie SA, Roche Ukraine LLC, Roche Vietnam Company Limited, Roche a/s Medicinalvarer og Kemikalier, Roche d.o.o., Roche d.o.o. farmaceutsko drustvo – Roche Ltd. Pharmaceutical Company, Roche farmacevtska družba d.o.o., Roche mtm laboratories AG, Roche s.r.o., Santaris Pharma, Sapac Corporation Ltd., Seragon Pharmaceuticals Inc., Shanghai Roche Pharmaceuticals Limited, Signature Diagnostics GmbH, Spark Therapeutics, Spring Bioscience Corp., Stratos Genomics, Syntex Corporation, Syntex Pharm AG, Syntex Pharmaceuticals International Limited, Syntex Puerto Rico Inc., Tanox Inc., Tavero AG, Tensha Therapeutics, Tensha Therapeutics Inc., Therapeutic Human Polyclonals, Therapeutic Human Polyclonals Inc., Trophos, Trophos SA, Tusk Therapeutics, Tusk Therapeutics Limited, UAB Roche Lietuva, Ventana Medical Systems, Ventana Medical Systems Inc., Verum Diagnostica GmbH, Viewics, Viewics Inc., Viewics India Private Limited, mySugr, mySugr GmbH, and mySugr Inc..
Read More
When was Roche founded?

Roche was founded in 1896.

How can I contact Roche?

Roche's mailing address is GRENZACHERSTRASSE 124, BASEL V8, CH-4070. The official website for the company is www.roche.com. The company can be reached via phone at (161) 688-1111, via email at investor.relations@roche.com, or via fax at 41-0-61-691-9391.

This page (OTCMKTS:RHHBY) was last updated on 8/15/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.